Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Xue-Fei Wu1,2, Chun Li3, Guang Yang4

  • 1Liaoning Provincial Key Laboratory of Cerebral Diseases, Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.

Frontiers in Pharmacology
|December 13, 2021
PubMed

Insights

This study investigates the therapeutic potential of novel compounds for treating neurodegenerative diseases. Findings highlight promising drug candidates for future clinical development in neurology.

Area of Science:

  • Pharmacology and Toxicology
  • Neuroscience
  • Drug Discovery

Context:

  • Neurodegenerative diseases pose a significant global health challenge.
  • Current treatments offer limited efficacy and symptom management.
  • There is a critical need for novel therapeutic strategies targeting disease mechanisms.

Purpose:

  • To identify and characterize novel small molecules with neuroprotective properties.
  • To evaluate the efficacy of these compounds in preclinical models of neurodegeneration.
  • To elucidate the molecular targets and pathways modulated by these potential therapeutics.

Summary:

  • Several novel compounds demonstrated significant neuroprotective effects in vitro and in vivo.
  • Key mechanisms include reduction of oxidative stress, modulation of protein aggregation, and anti-inflammatory actions.
  • Compound X showed particular promise, warranting further investigation for Alzheimer's and Parkinson's disease.

Impact:

  • This research contributes to the pipeline of potential treatments for debilitating neurodegenerative conditions.
  • Identified compounds could form the basis for new drug development, offering hope for patients.
  • The study provides valuable insights into the neuropharmacology of neuroprotection.

Related Concept Videos